Ursula Maria Vogl

16PUBLICATIONS
51CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsClinical pharmacology and therapeuticsPharmacogenomicsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 28, 2026
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression.

|Jan 25, 2026
Risk of bone fractures in patients with prostate cancer treated with maximal androgen blockade therapy: a systematic literature review and meta-analysis.

Isabella Saporita, Mariangela Calabrese, Federica Maria Carfi

|Aug 28, 2024
Impact of Neuroendocrine Differentiation (NED) on Enzalutamide and Abiraterone Efficacy in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Retrospective Analysis.

Giovanni Farinea, Mariangela Calabrese, Federica Carfì

|Jan 11, 2024
Synthetic Lethality by Co-Inhibition of Androgen Receptor and Polyadenosine Diphosphate-Ribose in Metastatic Prostate Cancer.

Mariangela Calabrese, Isabella Saporita, Fabio Turco

|Dec 14, 2023
Safety profile of darolutamide versus placebo: a systematic review and meta-analysis.

Fabio Turco, Silke Gillessen, Giorgio Treglia

|Feb 08, 2023
Darolutamide Maintenance in Patients With Metastatic Castration-Resistant Prostate Cancer With Nonprogressive Disease After Taxane Treatment (SAKK 08/16).

Silke Gillessen, Giuseppe Procopio, Stefanie Hayoz

Pageof 3

Frequent Collaborators

7 joint publications

Consuelo Buttigliero

5 joint publications

Massimo Di Maio

4 joint publications

Marco Donatello Delcuratolo

3 joint publications

Alessandro Audisio